L. Camuz Ligios

Impact of Tafamidis and Optimal Background Treatment on Physical Performance in Patients With Transthyretin Amyloid Cardiomyopathy

D. Bonderman, C. Binder, F. Duca, 2022, Circulation. Heart failure.

Impact of tafamidis on myocardial strain in transthyretin amyloid cardiomyopathy

D. Bonderman, C. Binder, F. Duca, 2022, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

Prognostic implications of pericardial and pleural effusion in patients with cardiac amyloidosis

C. Hengstenberg, T. Binder, H. Agis, 2020, Clinical Research in Cardiology.

What Type of Patients Did PARAGON-HF Select? Insights from a Real-World Prospective Cohort of Patients with Heart Failure and Preserved Ejection Fraction

C. Hengstenberg, D. Bonderman, C. Binder, 2020, Journal of clinical medicine.

Native skeletal muscle T1-time on cardiac magnetic resonance: A predictor of outcome in patients with heart failure with preserved ejection fraction.

C. Binder-Rodriguez, C. Doña, F. Duca, 2024, European journal of internal medicine.

Myocardial structural and functional changes in cardiac amyloidosis: insights from a prospective observational patient registry

C. Loewe, D. Beitzke, H. Agis, 2023, European heart journal. Cardiovascular Imaging.